The epigenetic landscape of hepatocellular carcinoma: from molecular mechanisms to early detection biomarkers and precision therapy.
Understanding liver cancer's epigenetic changes opens doors to new treatment strategies and personalized medicine approaches.
This PubMed-indexed study examined hepatocellular carcinoma (HCC) remains a leading cause of global cancer mortality due to late diagnosis, molecular heterogeneity, and therapeutic resistance. The abstract reports we highlight their translational potential in clinical practice and critically discuss current challenges, emerging technologies, and future perspectives for successful clinical implementation.
What the study was
- Study design
- Narrative Review
- Category
- Genomics/Precision Medicine
- Maturity
- Exploratory
- Journal
- Gene
Why it surfaced
Conservative triage based on the PubMed abstract: narrative review with direct watchlist relevance; score reflects metadata and abstract-level evidence only.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.